This study proposed a pathogenic model for ALS neurodegeneration, where astrocyte-specific release of soluble APP fragments activates DR6 on motor neuron surfaces, triggering death signals through an NF-κB1-dependent pathway leading to spinal motor neuron death [189]. Here, APP is linked to amyotrophic lateral sclerosis.